ISSN: 2167-0951

Hair Therapy & Transplantation
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 

Editorial Board

Editor Image

Editor-in-Chief
Mohamed Lotfy Elsaie
University of Miami School of Medicine
USA

Editor Image

Editor-in-Chief
Shigeki Inui
Osaka University Graduate School of Medicine
Japan

Editor Image

Sam Shuster
University of Newcastle upon Tyne
UK

View More»

Recommended Conferences

View More»
 

Submit Manuscript

Journal Impact Factor 0.608*
Submit manuscript at http://www.editorialmanager.com/medicaljournals or send as an e-mail attachment to the Editorial Office at editor.htt@omicsinc.com
 

About the Journal

 Hair Therapy and Transplantation is a medical and surgical process adapted to minimize hair loss and to promote hair growth.

Hair Therapy and Transplantation is a peer reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises peer reviewing of the submitted manuscripts for the quality of publishing.
Hair Therapy and Transplantation is one of the best open access journal that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide free access through online without any restrictions or any other subscriptions to researchers worldwide.
This top best scholarly journal is using Editorial Manager® System for quality in online manuscript submission, review and tracking system. Editorial board members of Hair: Therapy and Transplantation Journal or outside experts complete the review: at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript.
OMICS International organizes 300+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ scholarly open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members. Submit manuscript at http://editorialmanager.com/medicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.htt@omicsinc.com  
Aims and Scope

Androgenetic Alopecia

Androgenetic alopecia is a genetical disorder characterized by the gradual conversion of terminal hairs into indeterminate, and finally into vellus, hair. It is a common disease that affects men and women. The pattern of hair loss in women differs from male-pattern baldness.

Androgenic alopecia is hair loss that occurs due to an underlying susceptibility of hair follicles to androgenic miniaturization. Classic androgenic hair loss in males begins above the temples and vertex, or calvaria, of the scalp. As it progresses, a rim of hair at the sides and rear of the head remains. This has been referred to as a 'Hippocratic wreath', and rarely progresses to complete baldness. Androgenic alopecia is typically experienced as a "moderately stressful condition that diminishes body image satisfaction

Related Journals of Androgenetic Alopecia

Annals of DermatologyAmerican Journal of Clinical Dermatology, International Journal of Trichology, Annals of Dermatology, Australasian Journal of Dermatology, BMC Dermatology, British Journal of Dermatology, Case Reports in Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatology

Congenital Hypotrichosis

Congenital Hypotrichosis is a condition of no hair growth. Unlike alopecia, which describes hair loss where formerly there was hair growth, hypotrichosis describes a situation where there wasn't any hair growth in the first place. Hypotrichoses are conditions that affect individuals right from birth and usually stay throughout their lives.

Hypotrichosis is a common feature of Hallermann–Streiff syndrome as well as others. It can also be used to describe the lack of hair growth due to chemotherapy. Congenital hypotrichosis and atrichia are among the most complex areas of hair growth disorders, with several apparently distinctive entities. Numerous individuals have so far been described with decreased numbers of hair follicles, smaller follicles and/or fragile abnormal hairs

Related Journals of Congenital Hypotrichosis

Australasian Journal of Dermatology, BMC Dermatology, British Journal of Dermatology, Case Reports in Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatology

Congenital Alopecia

Congenital alopecia is the loss of hair, complete and absolute. More commonly it consists of alopecia, with scanty, incompletely grown, or lanugo-like hair. It is commonly associated with other defects like dental aplasias. In a few instances it was found in association with anomalies in the sweat glands, impaired senses of taste and smell and epidermolysis bullosa.

Alopecia as an outcome of chemotherapy for a malignancy can be very distressing. The loss of hair usually is temporary and the hair will grow back after the course of treatment is completed. Male patients may feel more comfortable wearing a hat or cap when out in public. Female patients who wish to wear a wig are encouraged to obtain one that is lightweight and the same color as their hair.

Related Journals of Congenital Alopecia

Dermatitis Journal, Clinical and Experimental Dermatology,  International Journal of Trichology, American Journal of Clinical Dermatology, Annals of Dermatology, Australasian Journal of Dermatology, BMC Dermatology, British Journal of Dermatology, Case Reports in Dermatology, Clinical, Cosmetic and Investigational Dermatology

Corticosteroids

Corticosteroids are man-made drugs that closely resemble cortisol, a hormone that adrenal glands produce naturally. Corticosteroids are different from the male hormone-related steroid compounds that some athletes abuse. It is class of chemicals that includes the steroid hormones produced in the adrenal cortex of vertebrates as well as the synthetic analogues.

Corticosteroids are a class of chemical substances that include steroid hormones that are produced in the adrenal cortex of vertebrates as well as the synthetic analogues of these hormones. Corticosteroids are involved in a wide range of physiological processes, including stress response, immune response, regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. E.g: Corticosterone, Cortisone, Aldosterone.

Related Journals of Corticosteroids

Steroids, Vitamins and Hormones, Hormones and Behavior, Hormones (Athens, Greece)

Female Pattern Hair Loss

Female Pattern Hair Loss (FPHL) occurs in approximately 50% of women by the age of 50 years old. Although it starts with increased shedding, over time the hair loss is characterized primarily by a decrease in hair density over the top of the scalp. Affected women note a decrease in the size of their hair.

Female pattern baldness involves a typical pattern of hair loss in women, due to hormones, aging, and genes. FPHL has a strong genetic predisposition. The mode of inheritance is polygenic, indicating that there are many genes that contribute to FPHL, and these genes could be inherited from either parent, or both. Genetic testing to assess risk of balding is currently not recommended, as it is unreliable. The majority of women with FPHL have normal levels of androgens in their bloodstream.

Related Journals of Female Pattern Hair Loss

British Journal of DermatologyInternational Journal of Trichology, Australasian Journal of Dermatology,BMC Dermatology, Case Reports in Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatology

Follicular Unit Extraction

Follicular Unit Extraction (FUE) is a method of “harvesting,” donor hair in a follicular unit hair transplant procedure. In FUE hair transplant surgery, an instrument is used to make a small, circular incision in the skin around a follicular unit, separating it from the surrounding tissue. The unit is then extracted directly from the scalp, leaving a small open hole.

In Follicular Unit Extraction harvesting, individual follicular units are extracted directly from the hair restoration patient's donor area, ideally one at a time. This differs from strip-harvesting because, in strip harvesting, a strip of skin is removed from the patient and then dissected into many individual follicular units. The follicular units obtained by either method are the basic building blocks of follicular unit transplantation

Related Journals of Follicular Unit Extraction

Transplantation, Transplantation Proceedings, Transplantation Reviews, American Journal of Transplantation, Stem Cell Research and Therapy

Frontal Fibrosing Alopecia

Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia with a distinctive clinical pattern of hair loss characterized by progressive recession of the frontotemporal hairline. This particular form of alopecia currently is considered a variant of lichen planopilaris because it is often accompanied by the the presence of cutaneous and/or mucous membrane lichen planus in patients.

Frontal fibrosing alopecia usually affects post-menopausal women over the age of 50. It is characterised by usually symmetrical band of hair loss on the front and sides of the scalp, and loss of eyebrows. The edge may appear moth-eaten, and single "lonely" hairs may persist in the bald areas. The skin in the affected area usually looks normal but may be pale, shiny or mildly scarred without visible follicular openings. At the margins of the bald areas, close inspection shows redness and scaling around hair follicles.

Related Journals of Frontal Fibrosing Alopecia

BMC DermatologyAmerican Journal of Clinical Dermatology, Annals of Dermatology, Australasian Journal of Dermatology, International Journal of Trichology

Hair Follicle

Hair Follicle is a sac from which a hair grows and into which the sebaceous (oil) glands open. It is lined by cells derived from the epidermal (outside) layer of the skin. Each follicle normally goes through a five-year cycle of growth, averaging about six inches (15 cm) of growth per year.

A hair follicle is a part of the skin, which grows a hair by packing old cells together. Attached inside the top of the follicle are sebaceous glands, which are tiny sebum-producing glands in almost all skin except on the palms, lips and soles of the feet. The thicker the hair, the more the number of sebaceous glandsThe average growth rate of healthy hair follicles on the scalp is nearly 0.5 inches (13 mm) per month.

Related Journals of Hair Follicle

Australasian Journal of Dermatology, Annals of Dermatology, BMC Dermatology, British Journal of Dermatology, Case Reports in Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatology

Hair Transplantation

Hair transplantation is a surgical procedure used to treat baldness or hair loss. Typically, tiny patches of scalp are removed from the back and sides of the head and implanted in the bald spots in the front and top of the head. It is a cosmetic procedure performed for significant hair loss, thinning hair, or bald spots.

Hair transplantation is a surgical technique that moves individual hair follicles from a part of the body called the 'donor site' to bald or balding part of the body known as the 'recipient site'. It is primarily used to treat male pattern baldness. In this minimally invasive procedure, grafts containing hair follicles that are genetically resistant to balding, like the back of the head, are transplanted to the bald scalp. Hair transplantation differs from skin grafting in that grafts contain almost all of the epidermis and dermis surrounding the hair follicle

Related Journals of Hair Transplantation

Transplantation, Transplantation Proceedings, Transplantation Reviews, American Journal of Transplantation, Current Stem Cell Research and Therapy

Hair Loss

Hair loss, or alopecia, is a concern for men, women, and children. Treatments for hair loss include medications such as Propecia and Rogaine, hair replacements, and hair restoration. It may be patchy or diffusive in manner.

Some types of hair loss can be caused by alopecia areata, an autoimmune disorder. The extreme forms of alopecia areata are alopecia totalis, which involves the loss of all head hair, and alopecia universalis, which involves the loss of all hair from the head and the body. Hair loss and hypotrichosis can have many causes, including fungal infection, traumatic damage, such as by compulsive pulling (trichotillomania), as a result of radiotherapy or chemotherapy, and as a result of nutritional deficiencies such as iron deficiency.

Related Journals of Hair Loss

Case Reports in Dermatology, Journal of Cosmotology & Laser Therapy, International Journal of Trichology, American Journal of Clinical Dermatology, Annals of Dermatology, Australasian Journal of Dermatology, BMC Dermatology, British Journal of Dermatology, Clinical and Experimental Dermatology, Clinical, Cosmetic and Investigational Dermatol

Lichen Planopilaris

Lichen planopilaris (LPP) is an uncommon inflammatory scalp disorder which is clinically characterized by perifollicular erythema, follicular hyperkeratosis, and permanent hair loss. LPP is considered a follicular form of lichen planus based upon shared pathologic features and the frequent coexistence of clinical findings of these disorders.

Lichen planopilaris typically presents as smooth white patches of scalp hair loss. No hair follicle openings can be seen in the areas of hair loss. At the edges of these patches there may be scale and redness around each hair follicle. Hairs can be easily pulled out. It is multifocal and small patches may merge to form larger irregular areas. lichen planopilaris is rare, it is one of the common causes of scarring hair loss of the scalp.

Related Journals of Lichen Planopilaris

Journal of Cosmetic Dermatology, BMC Dermatology, International Journal of Trichology, American Journal of Clinical Dermatology, Australasian Journal of Dermatology

Laser Therapy

Laser therapy is the non-invasive use of laser energy to generate a photochemical response in damaged or dysfunctional tissue. Laser therapy can alleviate pain, reduce inflammation and accelerate recovery from a wide range of acute and chronic clinical conditions. Laser therapy is a drug-free, surgery-free technique.

Laser therapy is a treatment that uses a strong beam of light to cut, burn, or destroy tissue. The term LASER stands for "Light Amplification by Stimulated Emission of Radiation." Lasers are more precise than traditional surgical instruments. Cuts can be made shorter and shallower. This causes less damage to tissue. Laser therapies are medical treatments that use focused light. Unlike most light sources, it is tuned to very specific wavelengths. This allows it to be focused into powerful beams.

Related Journals of Laser Therapy

Stem Cell Research and TherapyJournal of Cosmetic and Laser Therapy, Journal of Cosmetic Dermatology, Journal of Lasers in Medical Sciences, Lasers in Medical Science

Telogen Effluvium

Telogen effluvium is a form of non-scarring alopecia characterized by diffuse hair shedding, often with an acute onset. A chronic form with a more insidious onset and a longer duration also exists. It is a reactive process caused by a metabolic or hormonal stress or by medications.

It is a scalp disorder characterized by the thinning or shedding of hair resulting from the early entry of hair in the telogen phase (the resting phase of the hair follicle).Emotional or physiological stress may result in an alteration of the normal hair cycle and cause the disorder, with potential etiologies including eating disorders, fever, childbirth, chronic illness, major surgery, anemia, severe emotional disorders, crash diets, hypothyroidism, and drugs.

Related Journals of Telogen Effluvium

American Journal of Clinical Dermatology, Journal of Cosmetic Dermatology, International Journal of Trichology, Australasian Journal of Dermatology, BMC Dermatology

Minoxidil

 Minoxidil is used to stimulate hair growth and to slow balding. It is most effective for people under 40 years of age. Minoxidil has no effect on receding hairlines. It does not cure baldness; generally new hair is lost within a few months if the drug is stopped.

Minoxidil is an antihypertensive vasodilator medication. It also slows or stops hair loss and promotes hair regrowth. Minoxidil is generally well tolerated, but common side effects include burning or irritation of the eye, itching, redness or irritation at the treated area, as well as unwanted hair growth elsewhere on the body. Side effects of oral minoxidil may include swelling of the face and extremities, rapid and irregular heartbeat.

Related Journals of Minoxidil

Clinical and Experimental Dermatology, Case Report in Dermatology, Journal of Cosmetic Dermatology, International Journal of Trichology, Clinical, Cosmetic and Investigational Dermatology

Mycosis Fungoides

Mycosis fungoides is the most common form of a type of cancer called cutaneous T-cell lymphoma. Cutaneous T-cell lymphomas occur when certain immune cells, called T cells, become cancerous; these cancers affect the skin, causing different types of skin lesions.

The skin cells themselves are not cancerous. Mycosis fungoides usually occurs in adults over age 50, although affected children have been identified. Mycosis fungoides progresses slowly through several stageswith the condition progress through all stages. Most affected individuals initially develop skin lesions called patches, which are flat, scaly, pink or red areas on the skin that can be itchy. Cancerous T cells, which cause the formation of patches, are found in these lesions.

Related Journals of Mycosis Fungoides

Skin Research, Skin Research and Technology, Academic Journal of Cancer Research, Advances in Cancer Research

Stem Cell Therapy

Stem cell therapy, also known as regenerative medicine, promotes the reparative response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. Stem cells have the power to go to damaged areas and regenerate new cells and tissues by performing a repair and a renewal process, restoring functionality.

Stem cell therapy which involves replenishment of the lost stem cells. Stem Cell Therapy is a ground breaking treatment for hair re-growth. The stem cells encourage new hair growth within 3 to 4 months of therapy. Unlike other hair fall treatment. The follicle of hair include stem cells in the center of the follicle and these cells make sure a constant supply of cells for the fast development of hair cells. These stem cells are gradually lost which leads to baldness

Related Journals of Stem Cell Therapy

Stem Cell ResearchCurrent Stem Cell Research and Therapy, Journal of Cosmetic and Laser Therapy, Journal of Cosmetic Dermatology, Stem Cell Research and Therapy,

Tinea Capitis

Tinea capitis is a fungal infection of the scalp. It is also called ringworm of the scalp. It is a disease caused by superficial fungal infection of the skin of the scalp, eyebrows, and eyelashes, with a propensity for attacking hair shafts and follicles.

Related Journals of Tinea Capitis

Current Fungal Infection Reports, Epidemiology and Infection, International Journal of Trichology

Trigger Point Therapy

Trigger point massage therapy is specifically designed to alleviate the source of the pain through cycles of isolated pressure and release. In this, the recipient actively participates through deep breathing as well as identifying the exact location and intensity of the discomfort.

Related Journals of Trigger Point Therapy

Molecular Diagnosis and Therapy, Journal of Transplantation Technologies and Research

Journal Highlights

 

Major Disease Statistics

 
*Unofficial 2015 Journal Impact Factor was established by dividing the number of articles published in 2013 and 2014 with the number of times they are cited in 2015 based on Google search and the Scholar Citation Index database. If 'X' is the total number of articles published in 2013 and 2014, and 'Y' is the number of times these articles were cited in indexed journals during 2015 then, impact factor = Y/X

Recently Published Articles

 
Conventional Suture Material versus Staplers in the Closure of Donor Area in Hair Transplant. Which is Better?

 Syed Mubashir*, Peerzada Sajad , Farhan Rasool, Iffat Hassan, Yasmeen Jabeen and Sacchidanand S

 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version